← Open Payments lookup

DAVID ALLEN: Open Payments

NPI 1952371163 · HOLTON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$641 in 40 payments from 16 companies in 2025. Trend: 2023 $412 · 2024 $759 · 2025 $641

Food & beverage: $641
CompanyPaymentsAmount
ABBVIE INC.13$171
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$60
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$59
Novartis Pharmaceuticals Corporation3$48
AstraZeneca Pharmaceuticals LP3$45
Ascensia Diabetes Care Us Inc.2$34
Takeda Pharmaceuticals U.S.A., Inc.1$30
Novo Nordisk Inc2$29
Amgen Inc.2$29
Verona Pharma, Inc.2$27

Products named: VRAYLAR, CAPLYTA, XIFAXAN, UBRELVY, LEQVIO, AIRSUPRA, EOHILIA, Wegovy.

Industry payments across KS — which companies pay providers there.